Gilead Sciences, Inc. (GILD) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Gilead Sciences, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 17.94x | 239.97x | 17.85x | 23.46x | 14.65x | 595.39x |
| P/B Ratio | 6.75x | 5.96x | 4.43x | 5.07x | 4.33x | 4.02x |
| P/S Ratio | 5.19x | 4.01x | 3.73x | 3.95x | 3.34x | 2.97x |
| Profitability | ||||||
| Gross Margin | 78.8% | 78.3% | 76.0% | 79.3% | 75.8% | 81.5% |
| Operating Margin | 39.7% | 5.8% | 28.0% | 26.9% | 36.3% | 16.5% |
| Net Margin | 28.9% | 1.7% | 20.9% | 16.8% | 22.8% | 0.5% |
| EBITDA Margin | 46.1% | 15.4% | 38.7% | 32.4% | 41.5% | 16.7% |
| Liquidity | ||||||
| Current Ratio | 1.68x | 1.60x | 1.43x | 1.29x | 1.27x | 1.40x |
| Quick Ratio | 1.31x | 1.45x | 1.27x | 1.15x | 1.13x | 1.26x |
| Leverage | ||||||
| Debt/Equity | 1.09x | 1.38x | 1.09x | 1.19x | 1.27x | 1.73x |
YoY = year-over-year change. Source: FMP..